Navigation Links
Nuvilex, Inc. Sets Times and Locations for Upcoming Shareholder Meetings
Date:9/2/2009

CHERRY HILL, N.J., Sept. 2 /PRNewswire-FirstCall/ -- Nuvilex, Inc. (OTC Bulletin Board: NVLX), announces today the times and locations for its upcoming regional shareholder meetings. The meetings will provide shareholders with an opportunity to meet with senior management and learn about the Company's plans for the coming years. The Company requests that attendees register for the meetings via the Nuvilex web site at www.nuvilex.com. The registration page will be available on or before Friday, September 4, 2009.

September 16, 2009, 11:00 A.M. EDT, New York, New York

Hilton New York / East Midtown

304 East 42nd Street

New York, New York 10017

Tel. 1 (212) 986-8800

September 17, 2009, 11:00 A.M. CDT, Chicago, Illinois

Hilton Chicago O'Hare Airport

Room 2030, 2(nd) Floor

O'Hare International Airport

Chicago, IL 60666

Tel. 1 (773) 686-8000

September 18, 2009, 11:00 A.M. PDT, Los Angeles, California

Hilton Los Angeles Airport

Marina Room, 2(nd) Floor

5711 West Century Boulevard

Los Angeles, CA 90045

Tel. 1 (310) 410-4000

About Nuvilex, Inc.

Nuvilex, Inc. is an emerging healthcare consumer products company. The Company's lead products include: Last Shot Hangover Remedy(TM), a unique sugar-free, calorie-free and caffeine-free liquid formula designed to ease the symptoms of a hangover; Cinnergen(TM), which promotes a healthy glucose metabolism; Cinnechol(TM), designed to help maintain normal cholesterol levels and support normal cardiovascular function; and Infinitink(R), a permanent yet more easily removable tattoo ink. The Company's complete portfolio spans aesthetics, dermatology, environmental and nutraceutical products, all of which are designed to directly or indirectly improve human health. In March 2009, Nuvilex merged with Freedom2 Holdings, Inc., the developer of Infinitink(R). In conjunction with the merger, the Company changed its name to Nuvilex, Inc. from eFoodSafety.com. Please visit www.nuvilex.com for additional information on the Company.

Safe Harbor Statement

Statements contained in this presentation that are not strictly historical are "forward-looking" statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities and Exchange Act of 1934. The forward-looking statements are made based on information available as of the date hereof, and the Company assumes no obligation to update such forward-looking statements. Forward-looking statements are sometimes identified by words such as "intends", "anticipates", "believes", "expects", and "hopes" and involve a number of risks and uncertainties that could cause the Company's actual results to differ materially from projected results. All parties are cautioned that such forward-looking statements involve risks and uncertainties that could cause the Company's actual results to differ materially from those in these forward-looking statements. Such risks and uncertainties include but are not limited to demand for the Company's products and services, the planned share exchange with Freedom2 Holdings, Inc., our ability to secure additional financing, and other factors that may be more fully described in reports to shareholders and periodic filings with the Securities and Exchange Commission.

    Company Contact:

    Blair Barnes
    Senior Vice President and Chief Financial Officer
    Nuvilex, Inc.
    Ph: 856-433-6088
    Email: bbarnes@nuvilex.com

    Press Contact:

    Pat Arcand
    Arcand & Madison
    Ph: 617-576-7777
    Email: pat@am-pr.com


'/>"/>
SOURCE Nuvilex, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Nuvilex, Inc. Announces Business Update Conference Call
2. Nuvilex, Inc. Announces Monthly Investor Conference Call
3. Nuvilex, Inc. Announces Investor Conference Call and Open House
4. Nuvilex, Inc.s Marketing Partner, CK41 to Launch purEffect(TM) in May
5. Nuvilex, Inc. Announces New Pricing for Cinnergen and Launch of dLife Advertising and Promotion Campaign
6. Nuvilex, Inc. Launches Spring Break Initiatives Designed to Raise Visibility Among Key Demographic Group
7. eFoodSafety.com, Inc. Changes Name to Nuvilex, Inc., Reflecting New Strategic Direction of Company
8. Sometimes Angioplasty Can Wait
9. CancerCare(R) and the Tic Tac(R) Brand Attempt To Set a World Record in Times Square
10. Goold Health Systems Accelerates Backups by 5-times Using Arkeia Network Backup
11. Pharmacy Times Names New Editorial Director
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... Calif. (PRWEB) , ... March 24, 2017 , ... ... raised over $100,000 for its innovative EcoQube Frame vertical micro-veggies garden on ... instant demand for the product – with nearly 2,000 consumers (and counting) already ...
(Date:3/24/2017)... , ... March 24, 2017 , ... Viewers who like ... of critical historical facts, cultural practices, goods, services, and societal issues tend to appreciate ... look into the popular practice of utilizing running events for causes around the world. ...
(Date:3/24/2017)... ... ... “End Time GPS”: a dauntless and enlightened study of the second-coming of ... creation of published author, Wesley Gerboth, a World War II veteran, with a highly-regarded ... at age ninety-one, he shares the Wisdom God bestowed upon him in this publication. ...
(Date:3/23/2017)... (PRWEB) , ... March 23, 2017 , ... A recent ... for entry into teacher preparation programs. The NCTQ report suggests, based on a review ... requirements would significantly improve teacher quality in the U.S. It argues that this higher ...
(Date:3/23/2017)... ... March 23, 2017 , ... The IoT (Internet of ... connectivity are making a huge impact on businesses and individual consumers alike. Laboratories ... IoT will have a value anywhere from $4 trillion to $11 trillion dollars by ...
Breaking Medicine News(10 mins):
(Date:3/24/2017)...   The Accreditation Council for Medical Affairs ... the pharmaceutical industry has appointed Dr. Jane ... formed scientific advisory board. Dr. Chin will be ... ever medical affairs think tank within the pharmaceutical ... ACMA, please visit  www.medicalaffairsspecialist.org .  Connect with ...
(Date:3/24/2017)... DUBLIN , Mar. 24, 2017 Research and ... (IPF) Pipeline Analysis, 2016" report to their offering. ... The IPF pipeline is very strong with ... Corporation, Merck & Co., Inc., Biogen and Sanofi are involved in the ... candidates, of which one is in Phase III stage, 15 are in ...
(Date:3/24/2017)... -- Today Stock-Callers.com have issued research reports on ... (NASDAQ: NVCN), Hologic Inc. (NASDAQ: HOLX), Edwards Lifesciences Corp. (NYSE: ... These companies are part of the Healthcare sector, which gave ... rd , 2017, with the NYSE Health Care Index declining ... in the S&P 500 were down about 0.4% as a ...
Breaking Medicine Technology: